Expert Pulmonology Care in Ahmedabad

Multidrug-resistant tuberculosis (MDR-TB) is caused by TB bacteria that can no longer be treated with the two most powerful first-line anti-TB drugs—isoniazid and rifampicin.

Extensively drug-resistant tuberculosis (XDR-TB) is an advanced form of MDR-TB that is also resistant to at least one fluoroquinolone (such as levofloxacin or moxifloxacin) and one of the injectable second-line drugs (capreomycin, kanamycin, or amikacin).

• Prevalence: WHO reports that about 9.6% of patients with MDR-TB go on to develop XDR-TB. Cure rates for XDR-TB are around 20%, with mortality approaching 44% without timely treatment.
• Diagnosis: Comprehensive drug susceptibility testing (DST) using culture or rapid molecular tests (e.g., Xpert) is essential. Every MDR-TB case should be evaluated for XDR resistance to guide therapy.
• Treatment: Both MDR and XDR-TB require prolonged courses (18–24 months) of carefully selected second-line drugs. These medicines are less potent, more toxic, and more expensive than first-line therapy, making expert supervision critical.
• Curability: While challenging, cure is possible with early detection, strict adherence, and multidisciplinary support. Co-existing conditions like HIV can worsen outcomes, underscoring the need for comprehensive care and infection control.

Pleural biopsy is performed to determine why fluid or abnormalities have developed around the lung (pleural effusion) or within the pleural membrane. It can help diagnose tuberculosis, malignancy, collagen vascular disease, and other inflammatory conditions.

If a needle biopsy does not yield enough tissue for diagnosis, your pulmonologist may recommend a surgical or thoracoscopic biopsy to obtain a larger sample.

Normal Results

Pleural tissues appear healthy, without signs of inflammation, infection, or cancer.

Potential Findings

• Primary lung cancer
• Malignant mesothelioma
• Metastatic pleural tumors
• Collagen vascular disease
• Tuberculosis or other infections

Risks

There is a slight chance the needle may puncture the lung, causing a partial collapse (pneumothorax). This usually resolves on its own, but occasionally a chest tube is required. Excessive bleeding is rare but possible.

Considerations

If a closed pleural biopsy is not definitive, a surgical or thoracoscopic biopsy—performed under direct visualization—may be recommended. Your doctor will guide you on the best approach based on your overall health and imaging findings.

Transbronchial needle aspiration (TBNA) is a minimally invasive bronchoscopy technique that samples mediastinal and hilar lymph nodes without surgical mediastinal exploration.

• Diagnostic value: TBNA has proven sensitivity and accuracy for staging lung cancer, diagnosing sarcoidosis, and evaluating infections.
• Lymph node assessment: Diagnostic yield improves with larger node size; however, experienced bronchoscopists can successfully sample even small nodes with ultrasound guidance.
• Patient experience: The procedure is typically performed under conscious sedation; most patients go home the same day.

Discuss TBNA with your pulmonologist to determine whether the technique is appropriate for your condition and to understand preparation, recovery, and follow-up steps.

After Every Treatment

1. Switch off and unplug the compressor.
2. Disconnect the tubing from the air outlet.
3. Detach the face mask or mouthpiece and remove the medication cup cap.
4. Wash all accessories (except tubing) in warm water or mild detergent, rinse well, and let them air-dry.
5. Wipe the outer surface of the tubing; if droplets are present, run clean air through it for a few seconds.

Daily Disinfection (Once Every 24 Hours)

Soak accessories in 70% isopropyl alcohol for 5 minutes or 3% hydrogen peroxide for up to 30 minutes, then rinse with sterile or distilled water and air-dry. Boiling accessories for 5 minutes or using a steam sterilizer is another option. Do not wash disposable air filters—replace them as directed.

Compressor & Medication Care

• Keep the compressor covered and off the floor when not in use.
• Inspect compressor filters regularly; replace them when discolored.
• Store medications per the label, and discard any with color changes or crystals.
• Maintain backup supplies (medication cups, tubing, masks, filters, and even a spare compressor).

If you use ultrasonic or mesh nebulizers, follow the manufacturer’s instructions—avoid touching the mesh and nebulize sterile water after cleaning to clear residue.

Need a refresher? Connect with our clinical educator to review nebulizer technique and personalized maintenance tips.

Bupropion is a non-nicotine prescription medicine that reduces cravings and withdrawal symptoms, even in people without depression. It can be combined with nicotine replacement products under medical guidance.

• Who should avoid it? Individuals under 18, those who are pregnant, or anyone with a history of seizures, significant head injury, eating disorders, severe kidney disease, heavy alcohol use, or bipolar disorder.
• How to take it: Begin one week before your quit date. Take 150 mg once daily for three days, then increase to twice daily doses at least eight hours apart (swallow whole). Most courses last 7–12 weeks; longer use may be recommended to prevent relapse.
• Possible side effects: Dry mouth and insomnia are most common—taking the second dose in the afternoon can help. Stop immediately and seek medical advice if you experience mood changes, agitation, or suicidal thoughts.
• Supportive care: Pairing bupropion with counseling, quit plans, and follow-up visits improves success rates. Always consult your physician to confirm that the medication is appropriate for you.